InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 10/18/2017 8:47:53 AM

Wednesday, October 18, 2017 8:47:53 AM

Post# of 27623
BLRX - 1.09 Pre-market now at 1.13/1.15

BioLineRx Initiates Phase 1/2 Study of BL-8040 with Atezolizumab to Treat Gastric Cancer; Shares Up 1% Early



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.